4.7 Article

Discovery of new diaryl ether inhibitors against Mycobacterium tuberculosis targeting the minor portal of InhA

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Design, Synthesis, and Antifungal Activity of 4-Amino Coumarin Based Derivatives

Lu Xu et al.

Summary: A series of 4-amino coumarin-based succinate dehydrogenase inhibitors (SDHIs) were designed and synthesized. These compounds showed broad-spectrum antifungal activity against various plant pathogenic fungi in vitro. Among them, compounds 3n and 4e displayed excellent activity against Alternaria alternata and Alternaria solani.

MOLECULES (2022)

Review Biochemistry & Molecular Biology

An Update on Synthesis of Coumarin Sulfonamides as Enzyme Inhibitors and Anticancer Agents

Laila Rubab et al.

Summary: Coumarin is an important pharmacophore with diverse biological activities. Coumarin sulfonamide compounds have shown great development potential as clinical drugs for various diseases. This review discusses the recent progress in the synthesis and medicinal chemistry of coumarin sulfonamide-based compounds, particularly in the field of oncology and carbonic anhydrase inhibitors.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis

Nguyen-Hung Le et al.

Summary: Tuberculosis is a global health crisis with limited treatment options and drug resistance issues. Developing drugs targeting enzymes involved in cell envelope synthesis of Mycobacterium tuberculosis is crucial. Through a drug repurposing campaign, salicylanilide closantel and its derivatives were discovered as potential candidates for novel anti-tubercular drugs.

BIOORGANIC & MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Design, synthesis and biological evaluation of coumarin derivatives as potential BRD4 inhibitors

Qi-Hang Cui et al.

Summary: The structure of BRD(4)i ABBV-075 was modified and a novel series of coumarin derivatives were synthesized as BRD4 inhibitors. Compound 27d showed excellent inhibitory activities against various cancer cells and exhibited good stability, indicating it as a promising lead compound for further drug development.

BIOORGANIC CHEMISTRY (2022)

Article Chemistry, Multidisciplinary

Harnessing Dual-Fluorescence Lifetime Probes to Validate Regulatory Mechanisms of Organelle Interactions

Yuping Zhao et al.

Summary: This study proposed a new strategy to investigate the interaction regulatory mechanisms between endoplasmic reticulum and autophagosomes by developing dual fluorescence lifetime probes localized to these two organelles. The research revealed that motile autophagosomes at the tips of endoplasmic reticulum drive the growth and sliding of ER tubules, ER reticulate tubules form a three-way junction centered on autophagosomes, and ER autophagy serves as a cell damage index during drug-induced apoptosis.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Article Biochemistry & Molecular Biology

Novel diaryl ether derivatives as InhA inhibitors: Design, synthesis and antimycobacterial activity

Ola A. Abdelaziz et al.

Summary: A new series of diaryl ether derivatives were synthesized and evaluated as inhibitors of InhA enzyme, showing remarkable activities against different strains of Mycobacterium tuberculosis. Compounds 14, 19 and 24 exhibited the best MIC values and high binding affinities with the InhA enzyme, making compound 24 a potential lead compound for future development of new antitubercular drugs.

BIOORGANIC CHEMISTRY (2022)

Article Chemistry, Medicinal

Design and synthesis of 2-(2-isonicotinoylhydrazineylidene) propanamides as InhA inhibitors with high antitubercular activity

Vaclav Pflegr et al.

Summary: Novel compounds based on isoniazid scaffold were designed and synthesized with increased lipophilicity for improved antitubercular activity. The compounds exhibited excellent activity against susceptible and resistant strains of Mycobacterium tuberculosis, potentially inhibiting enoyl-acyl carrier protein reductase and showing promising prospects for drug discovery in tuberculosis treatment.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Synthesis and preliminary anticancer evaluation of new triazole bisphosphonate-based isoprenoid biosynthesis inhibitors

Thibaut Legigan et al.

Summary: A new series of triazole bisphosphonates with alkyl or phenyl substituents exhibited strong antiproliferative activity against human tumor cell lines, particularly the 4-hexyl and 4-octyltriazole bisphosphonates which were significantly more potent than zoledronate.Compound 8b was found to inhibit geranylgeranyl pyrophosphate biosynthesis in MIA PaCa-2 cells leading to tumor cell death.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

New InhA Inhibitors Based on Expanded Triclosan and Di-Triclosan Analogues to Develop a New Treatment for Tuberculosis

Sarentha Chetty et al.

Summary: The emergence of multidrug-resistant and extensively drug-resistant tuberculosis has highlighted the urgent need for the development of new anti-TB drugs. Through a rational structure-based drug-design approach and in silico molecular modelling, new flexible ligands were designed and synthesized as potential inhibitors against Mycobacterium tuberculosis. These compounds show promising inhibitory effects and offer opportunities for further optimization.

PHARMACEUTICALS (2021)

Article Biochemistry & Molecular Biology

Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents

Ashutosh Prasad Tiwari et al.

MOLECULAR DIVERSITY (2020)

Article Chemistry, Medicinal

Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents

Yinling Yun et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

Article Biochemistry & Molecular Biology

First triclosan-based macrocyclic inhibitors of InhA enzyme

Frederic Rodriguez et al.

BIOORGANIC CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors

Amaroju Suresh et al.

CHEMICAL BIOLOGY & DRUG DESIGN (2018)

Article Chemistry, Medicinal

Synthesis and antimycobacterial activity of 1-(beta-D-Ribofuranosyl)-4-coumarinyloxymethyl-/-coumarinyl-1,2,3-triazole

Smriti Srivastava et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Chemistry, Medicinal

An overview on crystal structures of InhA protein: Apo-form, in complex with its natural ligands and inhibitors

Aurelien Chollet et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Pharmacology & Pharmacy

Triclosan and its derivatives as antimycobacterial active agents

Rudolf Vosatka et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)

Article Chemistry, Multidisciplinary

Evaluating the Contribution of Transition-State Destabilization to Changes in the Residence Time of Triazole-Based InhA Inhibitors

Lauren A. Spagnuolo et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)

Article Chemistry, Medicinal

Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins

Marta Ferraroni et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Microbiology

Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3

Wei Li et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

Article Multidisciplinary Sciences

Discovery of cofactor-specific, bactericidal Mycobacterium tuberculosis InhA inhibitors using DNA-encoded library technology

Holly H. Soutter et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Chemistry, Multidisciplinary

Design, synthesis and evaluation of diphenyl ether analogues as antitubercular agents

Bharathkumar Inturi et al.

RSC ADVANCES (2016)

Article Medicine, General & Internal

Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor

Maria Martinez-Hoyos et al.

EBIOMEDICINE (2016)

Article Chemistry, Medicinal

Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth

Aurelien Chollet et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Cell Biology

Direct inhibitors of InhA are active against Mycobacterium tuberculosis

Ujjini H. Manjunatha et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Article Chemistry, Inorganic & Nuclear

Luminescent alkynyl-gold(I) coumarin derivatives and their biological activity

Julia Arcau et al.

DALTON TRANSACTIONS (2014)

Article Medicine, Research & Experimental

Towards a new tuberculosis drug: pyridomycin - nature's isoniazid

Ruben C. Hartkoorn et al.

EMBO MOLECULAR MEDICINE (2012)

Article Biochemistry & Molecular Biology

A Common Mechanism of Inhibition of the Mycobacterium tuberculosis Mycolic Acid Biosynthetic Pathway by Isoxyl and Thiacetazone

Anna E. Grzegorzewicz et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Biochemistry & Molecular Biology

Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane

Anna E. Grzegorzewicz et al.

NATURE CHEMICAL BIOLOGY (2012)

Article Biochemical Research Methods

Data processing and analysis with the autoPROC toolbox

Clemens Vonrhein et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)

Article Chemistry, Multidisciplinary

Phosphonated calix[4]arene-based amphiphiles as scaffolds for fluorescent nano-fibres

Adam D. Martin et al.

CHEMICAL COMMUNICATIONS (2011)

Article Chemistry, Multidisciplinary

Unified Syntheses of Cavicularin and Riccardin C: Addressing the Synthesis of an Arene Adopting a Boat Configuration

Sarah L. Kostiuk et al.

CHEMISTRY-A EUROPEAN JOURNAL (2011)

Article Biochemical Research Methods

Molecular replacement with MOLREP

Alexei Vagin et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Biochemical Research Methods

XDS

Wolfgang Kabsch

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Biochemistry & Molecular Biology

A Slow, Tight Binding Inhibitor of InhA, the Enoyl-Acyl Carrier Protein Reductase from Mycobacterium tuberculosis

Sylvia R. Luckner et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Biochemical Research Methods

Tools for integrated sequence-structure analysis with UCSF Chimera

Elaine C. Meng et al.

BMC BIOINFORMATICS (2006)

Article Chemistry, Medicinal

MolDock: A new technique for high-accuracy molecular docking

Rene Thomsen et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)

Article Biochemical Research Methods

Sulforhodamine B colorimetric assay for cytotoxicity screening

Vanicha Vichai et al.

NATURE PROTOCOLS (2006)

Article Biochemistry & Molecular Biology

High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis

Todd J. Sullivan et al.

ACS CHEMICAL BIOLOGY (2006)

Article Chemistry, Multidisciplinary

Ruthenium-catalyzed cycloaddition of alkynes and organic azides

L Zhang et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)

Article Biochemical Research Methods

Coot:: model-building tools for molecular graphics

P Emsley et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)

Article Chemistry, Multidisciplinary

UCSF chimera - A visualization system for exploratory research and analysis

EF Pettersen et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Targeting tuberculosis and malaria through inhibition of enoyl reductase

MR Kuo et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Biochemistry & Molecular Biology

Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid

SL Parikh et al.

BIOCHEMISTRY (2000)